NEUP
Neuphoria Therapeutics
$3.06
−$0.30 (−8.93%)Oct 29, 2026
Key metrics
The numbers that frame NEUP today
- Market cap
- $16.56M
- Gross margin
- 100%
- EV / Sales
- 2.9
- ROIC
- 1,079.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.03
- 52wk High
- $5.53
Growth
Revenue and earnings trend for NEUP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NEUP
Is Neuphoria Therapeutics a good buy?
No. Neuphoria Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Neuphoria Therapeutics is selling at a very high price.
What is the market capitalization of NEUP?
Neuphoria Therapeutics's market capitalization is $16.56M.
What is the 52-week high for NEUP stock?
The 52-week high for Neuphoria Therapeutics is $5.53. The current close of $3.06 is 44.7% below that high.
What is the 52-week low for NEUP stock?
The 52-week low for Neuphoria Therapeutics is $3.03. The current close of $3.06 is 0.9% above that low.
Does NEUP stock pay dividends?
Neuphoria Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NEUP?
Neuphoria Therapeutics's Debt / Equity ratio is 0.